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Detection and Quantification of Ploidy,
Nuclearity, and DNA Synthesis in Rat
Hepatocytes after Administration of a
Peroxisome Proliferator
by J. A Styles
The peroxisome proliferator methylclofenapate (MCP) induces species-specific liver growth
and cancer in rats and mice. The acute hyperplastic effects of MCP were studied in rats given
MCP (25 mg/kg by daily gavage) and injected IP (0.5 mL, 50 mM) with bromodeoxyuridine (BrdU)
6 hrbefore each sampling time. The animals were killed at 6-hr intervals and hepatocyte suspen-
sions prepared from their livers by collagenase perfusion. The cells were stained with propidium
iodide (PI) and BrdU antibody combined with fluorescein isothiocyanate (FITC). DNA content
(PI-red fluorescence) and S phase (BrdU/FITC-green fluorescence) were analyzed simultaneous-
ly by two-parameter flow cytometry and the frequency of S phase in different ploidy classes
deternined. At the same time, S-phase cells from different ploidy groups were sorted onto slides
by fluorescence-activated cell sorting and examined microscopically to deternine the frequency
ofbinucleated cells undergoing DNA synthesis. The results show that MCP-induced acute hyper-
plasia occurs mainly in a sensitive subpopulation ofbinucleated hepatocytes.
Introduction
In most investigations of cell proliferation in vivo,
the population under study consists of mononuclear
diploid cells that undergo replication via normal, com-
plete division cycles. Because the principal phenomena
associated with the cell cycle (DNA replication and
mitosis) are sequential, only one is normally measured,
and it is usually adequate to quantify proliferative
activity by measuring the frequency of cells either in
S phase by autoradiography or by BrdU-antibody
immunohistochemistry (the labeling index); or the fre-
quency of cells undergoing mitosis (the mitotic index)
after injection ofcolchicine to arrest cells in metaphase.
The mammalian liver normally exhibits near-quies-
cent proliferative activity, but it is capable of very
Imperial Chemical Industries, Central Toxicology Laboratory,
Alderley Park, Macclesfield, Cheshire SK10 4TJ, UK.
Present Address: MRC Toxicology Unit, Medical Research
Council Laboratories, Woodmansterne Road, Carshalton, Surrey
SM5 4EF, UK.
This paper was presented at the Symposium on Cell Proliferation
and Chemical Carcinogenesis that was held January 14-16, 1992, in
Research Triangle Park, NC.
rapid regenerative cell division after toxic or physical
injury (1). In rats and mice, the liver also undergoes
non-regenerative hyperplasia after the administration
ofperoxisome proliferators (2).
The livers of rats and mice, unlike those of other
mammals, consist mainly of hepatocytes that contain
two classes of cells with respect to nuclei and several
ploidy classes. These classes of hepatocytes arise as
the result of modified cell-division cycles (3-5). The
peculiar cytological composition ofthe rodent liver has,
until recently, caused difficulties in measuring cellular
ploidy and cell proliferation and interpreting cell-cycle
observations. The presence of a karyotypically nonho-
mogeneous hepatocyte population has limited the accu-
racy with which DNA content and nuclearity can be
estimated in histological sections. Furthermore, the
use of autoradiography for the quantification of S-
phase synthesis in histological sections of liver has
been complicated not only by the problem of variable
ploidy and nuclearity, but also by the near impossibili-
ty of discerning morphological cellular detail obscured
by silver grains. The measurement of mitotic activity
in the rodent liver is also complicated by its peculiar
cytology. Here the problems encountered are similar
to those for S-phase activity; the ploidy and nuclearity
of sectioned mitotic figures cannot be assessed accu-
rately.J. A. STYLES
Materials and Methods
Chemicals. Pure methylclofenapate (MCP, no impuri-
ties detected by standard analytical techniques) was
obtained from Lancaster Synthesis (6). Bromodeoxy-
uridine (BrdU) was supplied by Sigma. Propidium
iodide was purchased from Polysciences. Purified anti-
BrdU antibody conjugated with fluorescein isothio-
cyanate (FITC) was obtained from Becton-Dickinson.
Corn oil was supplied by Kraft foods.
Animals. Male Alpk:AP strain rats, 200-250 g weight
were used. Environmental conditions were as described
previously (2). After treatment, the animals were killed
by deep anesthesia followed by exsanguination by
perfusionin groups ofthreeforeachtime and dose group.
Dosing. MCP or corn oil were administered by gavage
in a dosing volume of 0.5 mL/100 g body weight. MCP
was made up at a concentration of 5 mg/mL in corn oil
and administered at adose of25 mg/kgbodyweight (2)
Labeling of Cells in DNA Synthesis with BrdU.
BrdU was administered to all animals by IP injection
(0.5 mL of50 mM solution in water) 6 hrbefore killing.
Isolation and Preparation of Hepatocytes. The
procedure for isolation and preparation of hepatocytes
was as described previously (2,6-8). After collagenase
perfusion, the lobes ofthe liver were excised carefully
from each animal and placed in 30 mL ofice-cold PBS-
EDTA. The lobes were minced with scissors and the
crude cell suspension filtered through a fine mesh
gauze and centrifuged for 2 min at 20g. The super-
natant was removed by aspiration, the cells suspended
carefully in 30 mL of PBS-EDTA, and the centrifu-
gation and suspension was repeated twice. After the
final centrifugation, the cell pellet was reduced to
about 10 cm3 if necessary and fixed. The hepatocytes
were fixed by the dropwise addition of 20 mL of 70%
ethanol at -20°C while the pellet was slowly agitated
on a vortex. The cells were left overnight in a
refrigerator at 4°C. The fixed cells were further
prepared for flow cytometric analysis (2,6). Cells in S
phase were stained with BrdU-FITC, and all cell
nuclei were stained with PI.
Analysis of Hepatocytes for DNA Content, S
Phase, and Nuclearity by Flow Cytometry and
Microscopy. Cells were analyzed by two-parameter
flow cytometry using an Ortho 2150 Cytofluorograf.
Hepatocytes were illuminated by an argon laser at 200
mW and a wavelength of 488 nm: DNA content was
detected by PI fluorescence (red), and the presence of
BrdU monoclonal antibody was detected by FITC
fluorescence (green). Cells in S phase were sorted by
fluorescence-activated cell-sorting onto microscope
slides using the regions shown in Figure 1. The cells
were examined microscopically to determine their
nuclearity (2,6).
Results
S Phase Response in Hepatocytes. The incidence
of S phase in hepatocytes at time intervals after
administration of MCP is given in Figure 1. These
results show that the hyperplasia elicited by MCP
appears to be an acute, transient phenomenon.
Nuclearity Analysis. Figure 2 shows the frequency
of 2 x 2N hepatocytes. At the outset of dosing the
hepatocyte population consisted of approximately 10%
2N, 23% 2 x 2N, and 67% 4N celis. After the admin-
istration of25 mg/kg MCP, there was a decrease in the
proportion of2 x 2N cells to about 9% and an increase
in 4N cells to about 81% (data not shown), while the
fraction of2N cells remained unchanged.
S Phase Response in Nuclear Classes. Figure 3
shows the frequency of2 x2Nhepatocytes in Sphase as a
percentage ofthetotalhepatocytepopulation. There were
a few 4N hepatocytes containing label (data not shown),
andthese werepossiblyderived from2x2Ncells.
Discussion
Flow cytometry and fluorescence-activated cell sort-
ing, used in conjection with quantitative fluorescent
stains for DNA and fluorescently labeled antibodies to
BrdU (9-12), have permitted the rapid and precise
quantification ofcell proliferative activity in the rodent
liver. Studies using these techniques have revealed
that proliferative activity of hepatocytes may occur in
different subpopulations ofcells depending on the kind
of toxicological injury inflicted on the animal (2). The
chief deficiency in the use of flow cytometry is the
unavoidable loss of tissue architecture and the con-
comitant loss of information with respect to the
anatomical distribution of cell proliferative activity.
This problem may partly be overcome by combining
flow cytometry of hepatocyte suspensions obtained by
collagenase perfusion with light microscopy ofsections
of liver in which S phase cells are labelled with BrdU
and visualized by immunohistochemical stains.
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FIGURE 1. The incidence of rat hepatocytes in S phase (%) at time
intervals afteradministration of25 mg/kgmethylclofenapate.
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FIGURE 2. Frequency of binucleated hepatocytes (%) at time inter-
valsafterdosingrats with 25 mg/kgmethyiclofenapate.
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FIGURE 3. Incidence of S phase in binucleated hepatocytes (%) at
time intervals after administration of25 mg/kg MCP.
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